Recognition and management of anthrax--an update.
Swartz
M N
MN
Department of Medicine, Massachusetts General Hospital, Boston 02114-2696, USA.
D000881:Anthrax / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D022122:Anthrax Vaccines; D019072:Antibiotic Prophylaxis; D001408:Bacillus anthracis / Q000472:pathogenicity; D023482:Bioterrorism; D019411:Clinical Laboratory Techniques; D003937:Diagnosis, Differential; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000382:microbiology; D006801:Humans; D017053:Infection Control / Q000379:methods; D016920:Meningitis, Bacterial / Q000175:diagnosis / Q000382:microbiology; D010406:Penicillins / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D017192:Skin Diseases, Bacterial / Q000175:diagnosis / Q000382:microbiology*; D013171:Spores, Bacterial; D014774:Virulence
D022122:Anthrax Vaccines; D010406:Penicillins